Roche is trading at $60.95, up 3.01%, apparently in line with the broader healthcare rally following Democratic control of Congress.
- The healthcare sector was reported up 1.37% during the session.
- No clear company-specific announcement was found for November 4.
- Roche’s Q3 sales update and UBS rating change predate this session and do not establish the cause of the move.